KDIGO 2024 Lupus Nephritis Guideline Publishes in Kidney International
|
|
The KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis was released in the January 2024 issue of Supplement to Kidney International, with an Executive Summary published in the main pages of the journal. The guideline is also available on KDIGO Lupus Nephritis (LN) Guideline website, where additional resources will be released in the coming weeks. Developed under the stewardship of Co-Chairs Brad Rovin, MD (United States) and Jürgen Floege, MD (Germany), this guideline is an update of the LN chapter of the KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases.
Drawing from the latest approvals of belimumab and voclosporin by the FDA and EMA, the guideline provides updated recommendations and practice points for using these new therapies as add-on immunosuppressive agents in the management of LN. The development of the guideline followed an explicit process of evidence review and appraisal. As part of KDIGO’s transparent guideline development process, the draft guideline was made available for public comment in March 2023, receiving valuable feedback, which was meticulously reviewed and considered by the Guideline Work Group.
"We are thrilled to publish the Lupus Nephritis Guideline, which follows only two years after the publication of the KDIGO Glomerular Diseases Guideline and reflects the latest advancements in the field,” said Dr. Rovin. "This guideline offers critical insights into navigating the complexities of LN treatment, especially with the introduction of novel therapies, and highlights the need for individualized therapy selection based on patient-specific factors and clinical scenarios. With ongoing trials evaluating additional novel therapeutics and promising new data on the horizon, the guideline sets the stage for future advancements in the management and treatment of LN.”
|
|
KDIGO Announces Retirement of CEO John Davis |
|
KDIGO announced the retirement this month of its Chief Executive Officer (CEO), John Davis. Mr. Davis has been the head of KDIGO since its inception. He has led the nephrology guideline development process since 1985, first with the National Kidney Foundation and for the last 12 years with KDIGO as an independent organization.
Mr. Davis will assume the role of CEO-Emeritus and will remain involved with the organization as a volunteer. Danielle Green, KDIGO Executive Director, will assume the role of CEO. Ms. Green was part of the KDIGO founding team and has been instrumental in assuring the organization's financial base and its relationships with key volunteers and corporate sponsors.
Mr. Davis said, "I'll miss the day-to-day progress and work of KDIGO, but I know that Danielle will step right in and keep KDIGO's progress on track. She is the ideal person for the role, is globally oriented, and is highly respected by our team and partners. I'm incredibly proud of KDIGO's reputation for high standards and competence built through the hard work of our team and volunteer leaders. It has been a pleasure and honor to lead the staff and work with renowned nephrologists from around the world on important programs that help our patients."
KDIGO Co-Chair Morgan Grams, MD (United States) said, "John has been a cornerstone of KDIGO's journey, shaping it into the impactful organization it is today. His visionary leadership has left an indelible mark and set us on a path to future success. We're profoundly thankful for John's dedicated service and the invaluable guidance he has provided. While we bid farewell to him as CEO, we look forward to continued collaboration in different capacities in the future."
Dr. Grams added, "The Executive Committee of KDIGO recently welcomed John Davis as CEO Emeritus and appointed Danielle Green as the new CEO. She has built excellent relationships with hundreds of volunteer nephrology leaders across the five continents. We are thrilled that she accepted the position."
KDIGO Co-Chair Michel Jadoul, MD (Belgium) said, "John Davis has been the guiding force behind KDIGO, steering it with unwavering dedication and wisdom. KDIGO simply wouldn't be what it is today without his unparalleled commitment and expertise. His legacy will continue to inspire and guide us as we move forward. We extend our deepest gratitude for his invaluable contributions to the organization, his colleagues, and the mission of improving outcomes for people with kidney disease worldwide."
|
|
KDIGO Podcast Series on Primary Care and CKD
KDIGO has released a 4-episode series of the Conversations in Nephrology Podcast. The new series, hosted by Peter Lin, MD (Canada), focuses on primary care and CKD. You can listen to the latest episodes on all major podcast platforms, ReachMD, and the KDIGO Podcast Website.
Conversations include:
- Episode 13: Early Detection of CKD with Lekha Tummalapalli, MD (United States)
- Episode 14: CKD Evaluation and Measurement with Magdalena Madero, MD (Mexico)
- Episode 15: Applying CKD Interventions with Joel Topf, MD (United States)
- Episode 16: Appropriate CKD Referral to Specialists with Ikechi Okpechi, MD (Canada)
|
|
Resources for Managing Symptom-Based Complications in Dialysis |
|
People on dialysis often experience and report distressing symptoms. Recognizing the burden of these symptoms on patients, KDIGO continues to pursue ways to empower clinicians to identify and manage these symptoms.
The recording of the last month's ISN-KDIGO Webinar on Symptom-Based Complications in Dialysis, which was based on the KDIGO Controversies Conference, is now available on the KDIGO YouTube channel and the ISN Academy. The webinar features conference co-chairs Raj Mehrotra, MD (United States), and Edwina Brown, MD (United Kingdom). The webinar also features conference attendee and patient, Dawn Edwards (United States).
|
|
Free KDIGO-PlatformQ Health CME Program: Beyond RAS Inhibition for IgAN: Guideline-directed Treatment and Emerging Therapies to Achieve Proteinuria Goals and Preserve Kidney Function
Available On-Demand
Join a panel of expert nephrologists during our free, virtual CME program produced in partnership with PlatformQ Health. Don't miss this exciting program on therapies for immunoglobulin A nephropathy (IgAN), and the correlation between proteinuria, pathophysiologic changes, and disease progression. Register now.
|
|
About KDIGO
KDIGO is a Belgian foundation committed to developing and implementing nephrology guidelines that improve outcomes for people with kidney disease on a global basis. KDIGO is independent, volunteer-led, self-managed, and accountable to the public and the people it serves.
|
|
|
|
|
|
|
